Książki na temat „Efficacy and quality of the drug product”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 35 najlepszych książek naukowych na temat „Efficacy and quality of the drug product”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.
1940-, Cartwright A. C., and Matthews Brian, eds. International pharmaceutical product registration: Aspects of quality, safety and efficacy. Ellis Horwood, 1994.
Znajdź pełny tekst źródłaJameel, Feroz, Susan Hershenson, Mansoor A. Khan, and Sheryl Martin-Moe, eds. Quality by Design for Biopharmaceutical Drug Product Development. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2316-8.
Pełny tekst źródłaKhan, Mansoor A., Feroz Jameel, Susan Hershenson, and Sheryl Martin-Moe. Quality by design for biopharmaceutical drug product development. Springer, 2015.
Znajdź pełny tekst źródła1940-, Cartwright A. C., and Matthews Brian, eds. International pharmaceutical product registration. 2nd ed. Informa Healthcare, 2009.
Znajdź pełny tekst źródłaGreat Britain. Medicines Control Agency., ed. Towards safe medicines: A guide to the control of safety, quality and efficacy of human medicines in the United Kingdom. HMSO, 1993.
Znajdź pełny tekst źródłaQuality, American Society for, ed. Data integrity and compliance: A primer for medical product manufacturers. ASQ Quality Press, 2019.
Znajdź pełny tekst źródłaRandall, Jonathan A. Issues and impacts of foreign pharmaceuticals. Nova Science, 2011.
Znajdź pełny tekst źródłaUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. Counterfeit bulk drugs: Hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000. U.S. G.P.O., 2000.
Znajdź pełny tekst źródłaR, Berndt Ernst, and National Bureau of Economic Research., eds. The roles of marketing, product quality and price competition in the growth and composition of the U.S. anti-ulcer drug industry. National Bureau of Economic Research, 1994.
Znajdź pełny tekst źródłaOffice, General Accounting. Drug safety: Most drugs withdrawn in recent years had greater health risks for women. U.S. General Accounting Office, 2001.
Znajdź pełny tekst źródłaOffice, General Accounting. Medical technology: Quality assurance systems and global markets : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. The Office, 1993.
Znajdź pełny tekst źródłaWeinberg, Sandy. Cost-contained regulatory compliance: For the pharmaceutical, biologics, and medical device industries. John Wiley & Sons, 2011.
Znajdź pełny tekst źródłaNichols, Eve K. Expanding access to investigational therapies for HIV infection and AIDS: March 12-13, 1990, conference summary. National Academy Press, 1991.
Znajdź pełny tekst źródłaCartwright, A. C., and Brian Matthews. International Pharmaceutical Product Registration: Aspects of Quality, Safety and Efficacy. Taylor & Francis Group, 2013.
Znajdź pełny tekst źródłaScientific Foundations for Regulating Drug Product Quality. AAPS Press, 1997.
Znajdź pełny tekst źródłaYarnell, Eric, Kathy Abascal, and G. M. D. Hooper Carol. Botanical Medicine: Efficacy, Quality Assurance and Regulation. Mary Ann Liebert, 1999.
Znajdź pełny tekst źródłaKhan, Mansoor A., Feroz Jameel, Susan Hershenson, and Sheryl Martin-Moe. Quality by Design for Biopharmaceutical Drug Product Development. Springer New York, 2016.
Znajdź pełny tekst źródłaPhillips, Joseph, and Satish K. Singh. Quality by Design Model for Biologics Drug Product Development. Wiley & Sons, Incorporated, John, 2020.
Znajdź pełny tekst źródłaKolhe, Parag, Mrinal Shah, and Nitin Rathore. Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations. Springer London, Limited, 2013.
Znajdź pełny tekst źródłaKolhe, Parag, Mrinal Shah, and Nitin Rathore. Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations. Springer New York, 2016.
Znajdź pełny tekst źródłaKolhe, Parag, Mrinal Shah, and Nitin Rathore. Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations. Springer, 2013.
Znajdź pełny tekst źródłaRahman, Mahfoozur, Sarwar Beg, Sunil Kumar Panda, Syed Sarim Imam, and Majed Al Robaian. Pharmaceutical Drug Product Development and Process Optimization: Effective Use of Quality by Design. Apple Academic Press, Incorporated, 2020.
Znajdź pełny tekst źródłaRahman, Mahfoozur, Sarwar Beg, Sunil Kumar Panda, Syed Sarim Imam, and Majed Al Robaian. Pharmaceutical Drug Product Development and Process Optimization: Effective Use of Quality by Design. Apple Academic Press, Incorporated, 2020.
Znajdź pełny tekst źródłaRahman, Mahfoozur, Sarwar Beg, Sunil Kumar Panda, Syed Sarim Imam, and Majed Al Robaian. Pharmaceutical Drug Product Development and Process Optimization: Effective Use of Quality by Design. Apple Academic Press, Incorporated, 2020.
Znajdź pełny tekst źródłaRahman, Mahfoozur, Sarwar Beg, Sunil Kumar Panda, Syed Sarim Imam, and Majed Al Robaian. Pharmaceutical Drug Product Development and Process Optimization: Effective Use of Quality by Design. Apple Academic Press, Incorporated, 2020.
Znajdź pełny tekst źródłaFDA inspections: A guide for medical device and diagnostic manufacturers. Interpharm Press, 1997.
Znajdź pełny tekst źródłaMedical technology: Quality assurance systems and global markets : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. The Office, 1993.
Znajdź pełny tekst źródłaMedical technology: Quality assurance systems and global markets : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. The Office, 1993.
Znajdź pełny tekst źródłaWelch, Mary R., and Craig Nolan. Chemotherapy and Radiation Therapy. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0143.
Pełny tekst źródłaLi, Madeline, Joshua Rosenblat, and Gary Rodin. Psychopharmacologic Management of Anxiety and Depression. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190491857.003.0005.
Pełny tekst źródłaWakeman, Sarah E., and Josiah D. Rich. Pharmacotherapy for substance use disorders within correctional facilities. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199360574.003.0046.
Pełny tekst źródłaWakeman, Sarah E., and Josiah D. Rich. Pharmacotherapy for substance use disorders within correctional facilities. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199360574.003.0046_update_001.
Pełny tekst źródłaZhang, Weiya, and Michael Doherty. Guidelines. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0037.
Pełny tekst źródłaMedicine, Institute of, and Roundtable for the Development of Drugs and Vaccines Against AIDS. Expanding Access to Investigational Therapies for HIV Infection and AIDS. National Academies Press, 1991.
Znajdź pełny tekst źródłaExpanding Access to Investigational Therapies for HIV Infection and AIDS. National Academies Press, 1991.
Znajdź pełny tekst źródła